发明申请
US20130259952A1 TIE2 Activator, Vascular Endothelial Growth Factor (VEGF) Inhibitor, Angiogenesis Inhibitor, Vascular Maturing Agent, Vascular Normalizing Agent and Vascular Stabilizing Agent, and Pharmaceutical Composition
审中-公开
基本信息:
- 专利标题： TIE2 Activator, Vascular Endothelial Growth Factor (VEGF) Inhibitor, Angiogenesis Inhibitor, Vascular Maturing Agent, Vascular Normalizing Agent and Vascular Stabilizing Agent, and Pharmaceutical Composition
- 申请号：US13905536 申请日：2013-05-30
- 公开(公告)号：US20130259952A1 公开(公告)日：2013-10-03
- 发明人： Nobuaki OHTO , Akinori KISO
- 申请人： Maruzen Pharmaceuticals Co., Ltd.
- 优先权： JP2010-269800 20101202; JP2011-105695 20110510; JP2011-105696 20110510; JP2011-151593 20110708
- 主分类号： A61K36/734
- IPC分类号： A61K36/734 ; A61K36/53 ; A61K36/62 ; A61K36/48 ; A61K36/61 ; A61K36/88 ; A61K36/16 ; A61K35/56 ; A61K36/9066 ; A61K36/287 ; A61K36/725 ; A61K36/815 ; A61K36/185 ; A61K36/67
摘要：
A Tie2 activator containing, as an active ingredient, a hawthorn extract, a starfruit extract, a shellflower extract, a lotus extract, a rooibos extract, an Indian date extract, a Chinese quince extract, a Psidium guava extract, a long pepper extract, a Quillaja extract, a Kouki extract, a ginkgo extract, an oyster extract, a turmeric extract, a chrysanthemum extract, a jujube extract, a Chinese wolfberry extract, a chamomile extract, or a Butcher's Broom extract, or any combination thereof.
IPC结构图谱:
| A | 人类生活必需 |
| --A61 | 医学或兽医学；卫生学 |
| ----A61K | 医用、牙科用或梳妆用的配制品 |
| ------A61K36/00 | 含有来自藻类、苔藓、真菌或植物或其派生物，例如传统草药的未确定结构的药物制剂 |
| --------A61K36/18 | .被子植物亚门 |
| ----------A61K36/185 | ..双子叶植物纲 |
| ------------A61K36/70 | ...蓼科，如刺花或酸模属 |
| --------------A61K36/734 | ....山楂属 |